We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

46 hedge funds and large institutions have $142M invested in Autolus Therapeutics in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.72% less ownership

Funds ownership: 27.43% → 23.71% (-3.7%)

8% less funds holding

Funds holding: 50 → 46 (-4)

38% less capital invested

Capital invested by funds: $230M → $142M (-$88M)

39% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 18

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
46
Holders Change
-4
Holders Change %
-8%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
11
Reduced
18
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GIM
Granahan Investment Management
Massachusetts
+$3.82M
2
JP Morgan Chase
JP Morgan Chase
New York
+$549K
3
Two Sigma Investments
Two Sigma Investments
New York
+$481K
4
Bank of America
Bank of America
North Carolina
+$419K
5
Franklin Resources
Franklin Resources
California
+$363K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$8.39M
2
Citadel Advisors
Citadel Advisors
Florida
-$8.21M
3
EP
Eversept Partners
New York
-$4.14M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$3.19M
5
AG
Artal Group
Luxembourg
-$1.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$232K – – –
TI
27
Trexquant Investment
Connecticut
$217K -$370K -25,547 -58%
Wells Fargo
28
Wells Fargo
California
$191K +$58.1K +4,007 +32%
BCM
29
Burrage Capital Management
Massachusetts
$175K – – –
Citadel Advisors
30
Citadel Advisors
Florida
$156K -$8.21M -565,976 -98%
AG
31
Aperio Group
California
$132K +$165K +11,372 New
Legal & General Group
32
Legal & General Group
United Kingdom
$100K – – –
TRCT
33
Tower Research Capital (TRC)
New York
$61K +$62.5K +4,313 +485%
Osaic Holdings
34
Osaic Holdings
Arizona
$58K -$36.3K -2,500 -33%
UBS Group
35
UBS Group
Switzerland
$38K -$23.8K -1,639 -33%
Citigroup
36
Citigroup
New York
$28K -$1.91K -132 -5%
Acadian Asset Management
37
Acadian Asset Management
Massachusetts
$24K -$32.4K -2,233 -52%
CFGS
38
Concourse Financial Group Securities
Alabama
$17K +$21.8K +1,500 New
US Bancorp
39
US Bancorp
Minnesota
$11K +$7.32K +505 +109%
LC
40
Lindbrook Capital
California
$6K – – –
PCM
41
Penserra Capital Management
California
$3K +$4.12K +284 New
ED
42
Exane Derivatives
France
$2.1K – – –
Daiwa Securities Group
43
Daiwa Securities Group
Japan
$2K – – –
Millennium Management
44
Millennium Management
New York
$1.73K -$8.39M -578,521 -80%
Barclays
45
Barclays
United Kingdom
$1K – – –
EP
46
Eversept Partners
New York
– -$4.14M -258,360 Closed
LCM
47
Laurion Capital Management
New York
– -$1.08M -67,519 Closed
DCM
48
DAFNA Capital Management
California
– -$1.03M -64,235 Closed
OM
49
Opaleye Management
Massachusetts
– -$962K -60,000 Closed
Squarepoint
50
Squarepoint
New York
– -$481K -30,018 Closed
1
2
3

AUTL Hedge Fund Activity: Q3 2020 in Review

46 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q3 2020, worth a combined $142M — down 38% from $230M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of AUTL and 5 opened new positions — a net loss of 4 holders — while 18 trimmed existing stakes and 11 added.

The largest buyer was Granahan Investment Management, adding an estimated $3.82M. The largest seller was Millennium Management, cutting an estimated $8.39M.

  • 46 institutional investors held Autolus Therapeutics (AUTL) as of Q3 2020, down from 50 in Q2 2020.
  • Funds reported $142M of Autolus Therapeutics stock for Q3 2020, down 38% quarter-over-quarter.
  • 5 funds opened new Autolus Therapeutics positions in Q3 2020 and 9 closed out, a net change of -4 holders.
  • The largest Autolus Therapeutics buyer in Q3 2020 was Granahan Investment Management, an estimated $3.82M added.
  • The largest Autolus Therapeutics seller in Q3 2020 was Millennium Management, an estimated $8.39M sold.

Based on aggregated 13F filings for Q3 2020.